Author:
Banys-Paluchowski Maggie,Krawczyk Natalia,Stickeler Elmar,Müller Volkmar,Fehm Tanja
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynecology
Reference20 articles.
1. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med,2001
2. Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study;Swain;Lancet Oncol,2020
3. Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer;Murthy;N Engl J Med,2020
4. Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer;Cortes;N Engl J Med,2022
5. Trastuzumab emtansine for HER2-positive advanced breast cancer;Verma;N Engl J Med,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献